Research Article - (2013) Volume 4, Issue 7

Spectrophotometric Studies of Lamotrigine Charge Transfer Complexes:Synthesis and Characterization

Najma Sultana1*, Saeed Arayne M2 and Saeeda Nadir Ali2
1Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, University of Karachi, Karachi-75270, Pakistan
2Department of Chemistry, University of Karachi, Karachi-75270, Pakistan
*Corresponding Author: Najma Sultana, Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, University of Karachi, Karachi-75270, Pakistan Email:

Abstract

Charge transfer complexes of lamotrigine with 7,7,8,8-tetracyanoquinodimethane, bromothymol blue and picric acid have been investigated by spectrophotometric method. Optimum conditions for the reactions and validation data is reported. Resulting complexes absorb at 394, 404 and 374 nm in the Beer’s law range of 0.15-15, 0.25- 10 and 3.0-18 µg mL-1 with correlation coefficient greater than 0.998 in each case and detection limits 45, 47 and 57 µg mL-1 respectively. The data are discussed in terms of molar absorptivity, association constant and Gibb’s free energy. Spectral characteristics including oscillator’s strength, dipole moment, ionization potential, energy of complexes and resonance energy have been determined. Benesi-Hildebrand plots for each complex have been constructed. The proposed method was applied successfully for the determination of lamotrigine in pharmaceutical formulations. Satisfactory recovery values suggested that the method is reliable for the determination of lamotrigine in pharmaceutical formulations without interference of excipients. Further, solid charge transfer complexes were synthesized and characterized by IR and 1H NMR spectroscopy.

Keywords: Charge transfer complexes; Lamotrigine; π acceptors; Dye stuffs; Benesi–Hildebrand plot

Introduction

Lamotrigine (LAM) is an anticonvulsant drug; belong to drug class of phenyltriazine. It is used to treat epilepsy, bipolar disorder and neurological lesions and also act as a tranquilizer [1,2]. Like other anticonvulsant, it also behaves as an effective mood stabilizer. Chemically it is 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine and its structural formula is given in Figure 1.

pharmaceutica-analytica-acta-Structure

Figure 1: Structure of LAM.

Many of the methods have been reported for the determination of LAM including HPLC and GC [3], capillary electrophoresis [4], titrimetry [5] and voltammetry [6]. Literature survey revealed a number of spectrophotometric methods for the determination of LAM [7] in acidic medium [8], in basic medium [9], through CT and ion pair complexes with bromophenol blue [10], bromocresol green [11], bromocresol purple [12], chlorophenol red [13], p-chloranilic acid [14], through oxidation of LAM [15].

Analysis of drugs employing spectrophotometric method is being carried out in our laboratory for few years. Methods for the determination of verapamil [16], gabapentin [17], quinolone antibiotics [18], metformin [19], ascorbic acid [20] and montelukast [21] have been developed spectrophotometrically by our research fellows. Currently, we are working on charge transfer complexes of gabapentin, ibuprofen, omeprazole and few other bulk drugs. In continuation of our work, this paper describes sensitive and rapid spectrophotometric method for the determination of LAM through charge transfer complexes with TCNQ, BTB and PA utilizing low cost easily available solvent. The method is simple and reports many of spectral characteristics including oscillator’s strength, dipole moment, ionization potential, energy of complexes, resonance energy and also the thermodynamic parameters i.e. association constant and Gibb’s free energy changes which have never been determined in previously reported methods. Benesi-Hildebrand plots for each complex have been constructed. Further, solid CT complexes of LAM were synthesized and characterized by IR and 1H NMR spectroscopy. Moreover, the developed methods have been successfully applied for the determination of LAM in pharmaceutical formulation without interference of excipients.

Experimental

Materials and reagents

LAM was obtained from Searle Pakistan Ltd and Lamnet® 25 mg was purchased from the local pharmacy. TCNQ and BTB were purchased from Merck (Darmstadt, Germany) and PA was purchased from Sigma Aldrich Chemie GmbH. All the solvents used were of analytical grade and double distilled de-ionized water was used throughout the analysis.

Apparatus

Electronic spectra of LAM and its complex were recorded in the region 200-800 nm using Shimadzu 1800 double beam UV–visible spectrophotometer version 3.9 software with quartz cells of 1.0 cm path length. The IR spectra were obtained from KBr discs using Shimadzu Prestige-21200VEC version 1.2 software and 1H NMR spectra were measured on Bruker AMX 500MHz spectrophotometer using TMS as internal standard and MeOD as solvent.

Standard stock solutions

– 0.39×10-2 M LAM in methanol

– 0.49×10-2 TCNQ in methanol

– 0.16×10-2 M BTB in double distilled deionized water

– 0.43×10-2 M PA in methanol

– Phthalate buffer of pH ranging from 2.2-4.0 was prepared by dissolving 20.4 g potassium hydrogen phthalate in 1.0 L distilled water and pH of solution was maintained by adding 0.1M HCl.

General Procedure

Method for TCNQ and PA

Aliquots of stock standard solution of LAM in the concentration range of 0.15-15 and 3.0-18 μgmL-1 were transferred into two separate series of 10 ml volumetric flasks; to each flask 1 mL of TCNQ and 1mL of PA were added in the respective series. These solutions were allowed to react at room temperature for 15 min. The volume was made up to the mark with methanol and the absorbance was measured against reagent blank treated similarly.

Method for BTB

LAM solution in the concentration range of 12-96 μgmL-1 was transferred in to 10 mL volumetric flaks, to this 3.0 mL buffer of pH 3.4 and 2.5 mL BTB solution was added and the volume was completed with distilled water. The mixture was then transferred into 50 mL separating funnel and extracted with 20 mL chloroform in two portions. The absorbance of extracted organic layer was measured against reagent blank treated similarly. The standard calibration graph was prepared by plotting absorbance vs. concentration of LAM.

Pharmaceuticals formulation

Twenty tablets of 25 mg Lamnet® were finely triturated. The powder equivalent to 100 mg of LAM was dissolved in methanol and shaken well for proper mixing. This solution was allowed to stand for 30 min and then sonicated for complete solubilization of drugs. Then the contents were filtered to separate the insoluble excipients and volume was completed with same solvent to get the final concentration of 1000 μgmL-1. The procedure was continued as described under the procedure for pure LAM.

Synthesis of solid CT Complexes

Solid CT complexes were synthesized by refluxing the LAM with each of the complexing agent separately for 2 hrs in the ratio of 1:1 as found through the stoichiometric study by applying Job’s method. The resulting product in each case was filtered off and washed with minimum amount of methanol. The excess solvent was evaporated to dryness. The solid CT complexes were characterized by UV-visible, IR and 1H NMR spectroscopy.

Results and Discussion

LAM, being a nitrogenous drug is present in the positively charged protonated form. It is reported to form CT complexes with many of compounds. In the present study, efforts have been made to develop the complexes of LAM with TCNQ, BTB and PA. It was observed that LAM interact with all of these agents in the stoichiometric ratio of 1:1 as determined by applying Job’s method of continuous variation [22] leading to the formation of bluish green, yellow and dark yellow CT complexes. In all resulting product, LAM is in positively charged protonated form, whereas TCNQ forms radical anion and sulfonephthalein group of BTB and hydroxyl group of PA form anion. The newly formed complexes show intense absorption bands at 394, 404 and 374 nm respectively. The electronic absorption spectra of these complexes are given in Figure 2.

pharmaceutica-analytica-acta-LAM-complexes

Figure 2: UV spectra of LAM complexes with (1) TCNQ, (2) BTB and (3) PA.

Different parameters influencing the intensity of absorption bands were investigated to establish the optimum experimental conditions for the assay. It was observed that the complete complexation occurs instantaneously for TCNQ and PA and absorbance remains constant for 24 hrs. The optimum reaction time for LAM-BTB complex was determined by investigating the absorbance of complex at every minute while shaking the reaction mixture. It is apparent from the Figure 3 that complete interaction occurs after proper shaking of mixture for 2 min and it also found to be stable for 24 hr. The effect of reagent concentration was examined by adding different volumes of 0.49×10-2 M TCNQ, 0.16×10-2 M BTB and 0.43×10-2 M PA in to a fixed amount of LAM. The 1 mL TCNQ and PA and 2.6 mL BTB were found to be appropriate for complete complexation. For BTB method, buffer of suitable pH was selected by testing them in the range of 2.0-4.0 and the maximum absorbance was obtained at pH 3.4. For proper extraction of complex, solvents like benzene, carbon tetra chloride, dichloromethane and chloroform were tested. Double extraction with chloroform was supposed to be adequate for maximum recovery.

pharmaceutica-analytica-acta-shaking-time

Figure 3: Effect of shaking time on LAM-BTB complex.

Analytical data

At the established experimental conditions, standard calibration curves for LAM with TCNQ, BTB and PA were constructed by plotting absorbance verses concentration. The linear regression curves were obtained in the Beer’s law range of 0.15-15, 0.25-10 and 3.0-18 μg mL-1 with correlation coefficient greater than 0.998 in each case respectively. Regression characteristics including slope, intercept, correlation coefficient and also the molar absorptivity values for each proposed method are given in Table 1. Limit of detection and quantitation were determined to establish the sensitivity of method. The LOD values were calculated to be 45, 47 and 57 μg mL-1 respectively (Table 1). Reproducibility of the method was measured for a series of six determinations at six concentration level. The data of percent relative standard deviation obtained for each method are reported in Table 2. The %RSD values in the range of 0.02-1.72, 0.05-0.45 and 0.31-1.28 confirm the sensitivity of method.

Parameters LAM-TCNQ LAM-BTB LAM-PA
λmax (nm) 394 404 374
Linearity range μgmL-1 0.15-15 0.25-10 3.0-18
Molar absorptivity 12258 19643 7436
Slope 3.56E-02 4.90E-02 2.43E-02
Intercept 0.0.0633 0.2719 0.0857
Correlation coefficient 0.9985 0.9986 0.9986
LOD ngmL-1 0.045882 0.047621 0.057616
LOQ μgmL-1 0.139038 0.144308 0.174594

Table 1: Optimum conditions and analytical parameters.

LAM-TCNQ LAM-BTB LAM-PA
Conc %RSD Conc %RSD Conc %RSD
0.15 0.33 1 0.05 3 0.32
3 1.72 2 0.18 6 0.61
6 0.62 4 0.15 9 2.28
9 0.14 6 0.18 12 0.31
12 0.70 8 0.45 15 0.77
15 0.02 10 0.24 18 1.27

Table 2: Precision of method.

Pharmaceutical formulation

The proposed method was successfully applied for the determination of LAM in its dosage formulation. Six determinations were made at three concentration levels. The results obtained are shown in Table 3. Satisfactory recovery data was obtained in the range of 98.93-100.88%, 99.75-99.78% and 99.54-100.88% for TCNQ, BTB and PA. The low percent error indicated the reliability of method. The assay results were in good agreement with the label claim. Also, the effect of commonly found excipients was determined by scanning the blank solution of LAM and the placebo solutions. The percent recovery values given in Table 4 indicate that excipients of tablet did not found to interfere during the assay.

LAM-TCNQ LAM-BTB LAM-PA
Conc % Rec % Err Conc % Rec % Err Conc % Rec % Err
3 100.47 0.46 2 99.75 -0.25 3 100.88 0.87
6 98.93 -1.08 4 99.78 -0.22 6 99.54 -0.46
9 100.88 0.87 6 99.75 -0.25 9 100.87 0.86

Table 3: Accuracy of method.

Excipients LAM-TCNQ LAM-BTB LAM-PA
% Recovery
Pyrrolidone 99.13 99.76 99.86
Lactose 98.61 100.22 100.30
Talc 100.40 99.29 100.46
Magnesium stearate 100.17 99.68 98.97
Starch 99.58 101.42 100.89

Table 4: Recovery of lamotrigine in presence of different excipients.

Spectral characteristics of CT complexes

The experimental oscillator strength (f) and transition dipole moment (μ) of newly formed CT complexes were determined by formulae given in equation (1) and (2) [23,24];

f = (4.319 × 10-9) εmax1/2 (1)

μ = 0.0958 (εmax1/2max)1/2 (2)

where εmax. is the molar extinction coefficient at maximum absorbance, ν1/2 is the band-width at half absorbance in cm-1 and νmax is wave number in cm-1. Relatively large values of oscillator strength indicate the strength of complexes. The ionization potential (Ip) of free donor was calculated by using the equation (3) [25],

Ip = 5.76 + 1.53 × 10-4 νCT (3)

where νCT is the wave number in cm-1 corresponding to the CT band of complex formed between donor and acceptor. The resonance energy of CT complex in the ground state was determined by Brieglab and Czekalla equation (4) given bellow [26]:

εmax = 7.7 × 10-4/ [hνCT/ RN-3.5] (4)

The energy of CT complexes was calculated by applying the relationship given in equation (5) [24]:

ECT=1243.667/λCT(5)

where λCT is the wavelength of CT band at maximum absorbance. All the spectral data including oscillator strength, dipole moment, ionization potential, resonance energy and energy of CT complexes are presented in Table 5.

The association constant was determined by employing Benesi- Hildebrand equation [27].

[Ao]/A = 1/K [Do]. ε + 1/ε (6)

where, K is the association constant, A is absorbance, e is molar extinction coefficient and [Ao] and [Do] are the initial concentrations of the acceptor and donor respectively. The values for Kc are given in Table 5. Further investigation was made by plotting the values of 1/D0 versus A0/A, which showed linear curve in all the cases. Table 6 presents the values and the graphs are displayed in Figure 4.

pharmaceutica-analytica-acta-BH-plot

Figure 4: BH plot for LAM complexes with (1) TCNQ, (2) BTB and (3) PA.

Complex f μ Ip ECT RN Kc ×102 (lit/mol) ΔG° (KCal)
LAM-TCNQ 12.31 32.11 9.64 3.16 0.90 2.06 3.15
LAM-BTB 9.53 28.61 9.55 3.08 0.88 9.56 4.06
LAm-PA 3.45 16.57 9.85 3.33 0.95 3.26 3.42

Table 5: Spectrophotometric results.

Complex D (M) × 10-3 A (M) × 10-3 Abs 1/D ×105 A/Abs × 10-2
LAM-TCNQ 0.023 4.90 0.2867 0.43 1.71
0.035 4.90 0.4033 0.28 1.22
0.047 4.90 0.4886 0.21 1.00
0.059 4.90 0.5868 0.17 0.84
0.070 4.90 0.8619 0.14 0.57
LAM-BTB 0.008 1.60 0.3932 1.28 0.41
0.016 1.60 0.4633 0.64 0.35
0.023 1.60 0.5574 0.43 0.29
0.031 1.60 0.6065 0.32 0.26
0.039 1.60 0.7673 0.26 0.21
LAM-PA 0.012 3.06 0.298 0.85 1.03
0.047 3.06 0.381 0.21 0.80
0.070 3.06 0.466 0.14 0.66
0.094 3.06 0.675 0.11 0.45
0.117 3.06 0.771 0.09 0.40

Table 6: The values of [A0] Abs and 1/ [D0] for lamotrigine complexes.

The standard free energy changes (ΔG°) associated with GBP complexation reactions were calculated from the association constants by applying equation (2) [28]. The values of ΔG° for each complex are given in Table 5.

ΔG° = -2.303RT log KC (7)

where, ΔG° is the free energy change of the complex in KJ mol-1, R is the gas constant (1.987 cal mol-1 deg-1), T is temperature in Kelvin and Kc is the association constant of drug-acceptor complexes.

Spectroscopic study

Spectroscopic studies of free donor and formed complexes were carried out to determine the structure of complexes. The IR spectra (Figure 5) were recorded using KBr discs and 1H NMR spectra were measured at room temperature in MeOD. The IR spectra of LAM shows characteristic peak of -NH2 at 3350 cm-1 which shift to 3450, 3448 and 3215 cm-1 in LAM complexes with TCNQ, BTB and PA respectively, confirming that the interaction has occurred at -NH2 site. The infrared frequencies and band assignments are given in Table 7 and the chemical shift values for the detected peaks are mentioned in Table 8. On the basis of spectroscopic data, the proposed chemical structure of LAM complexes with TCNQ, BTB and PA are given in Figure 6.

pharmaceutica-analytica-acta-IR-spectra

Figure 5: IR spectra of LAM complexes with (1) TCNQ, (2) BTB and (3) PA.

pharmaceutica-analytica-acta-Proposed-structure

Figure 6: Proposed structure of LAM complexes with (1) TCNQ, (2) BTB and (3) PA.

LAM LAM-TCNQ LAM-BTB LAM-PA Assignment
3350 3450 3448 3215, 3856 ν(N-H)
2954,2850 2924, 2858 2924 2924 ν(C-H)
- - - 1653, 1683 ν(NO2)
1560 1560 1558 1583 ν(C=N)
1541 1541 1541 1546 ν(C=C)
1502 - 1506 1506 ν(N-H)
1440 1462, 1440 1460 1460 ν(C-H) deformation
1327 1346 1300 1328 ν(C-N)
1382 - 1342 1382 ν(C-C)
- 1174 1172 1237 ν(C-O)
1157 1163 1163 1159 ν(C-H) in plane
- - - 1035 ν( NO2)
- - 1018 - ν(S=O)
846 842 853 846 δrock CH2
- - 613 - ν( S-O)

Table 7: Infrared frequencies and their assignments.

Assignment LAM LAM-TCNQ LAM-BTB LAM-PA
(s, NH2) δ 4.83 δ 4.56 δ 4.52 δ 4.56
(m, arayl) δ 7.34-7.66 δ 7.40-7.73 δ 6.94-7.67 δ 7.34-7.71
(d, 4CH3) - - δ 0.991 -
(s, CH3) - - δ 1.99 -
(s, CH3) - - δ 2.13 -
(m, 2CH) - - δ 3.29 -

Table 8: 1H NMR spectra.

Advantages over reported methods

For the determination of LAM several techniques have been applied. A number of articles have been published for its determination in bulk drug, commercial formulations, biological and clinical samples. Recently, different reported spectrophotometric methods have been compared by vinay et al. [8] with their reported methods. Almost all of the previously reported methods are relatively less sensitive, time consuming or require the expensive reagents. In comparison, present study describe simple and more sensitive UV/ visible method based on the formation of charge transfer complexes of LAM with easily available reagents like TCNQ, BTB and PA. Simple methodology is applied and results are calculated without employing any complicated equations. Moreover, none of the reported methods explicate the spectral characters of LAM and its complexes. Here, we reported the oscillator’s strength, dipole moment, ionization potential, energy of complexes, resonance energy, association constant and Gibb’s free energy changes and constructed the Benesi-Hildebrand plot in each case. The interday and intraday precision and percent recovery values were evaluated. Results of analysis were validated successfully. These methods were successfully applied for the determination of LAM in pharmaceutical formulations. Commonly present excipients did not show interference during analysis. Solid charge transfer complexes were synthesized and characterized by IR and 1H NMR spectroscopy.

Conclusion

The aim of present study was

• Development of charge transfer complexes of LAM with TCNQ, BTB and PA.

• Application of developed complexes for the UVspectrophotometric determination of LAM in bulk and its formulation.

The investigation comprised the determination of its spectral characteristics including oscillator’s strength, dipole moment, ionization potential, energy of complexes, resonance energy, association constant and Gibb’s free energy changes. Benesi-Hildebrand plots for each complex have been constructed. Also, the solid CT complexes were synthesized and characterized by IR and 1H-NMR spectroscopy. Further, LAM was determined in bulk and its formulation by means of charge transfer complexes. Calibration graphs plotted between absorbance verses concentration of LAM were found to be linear within the limit of Beer’s law with correlation coefficient greater than 0.998. The assay results were in good agreement with the label claim. Commonly present excipients did not found to interfere during the assay.

Acknowledgements

The author Mrs Saeeda Nadir Ali is grateful to Higher Education Commission, Pakistan for providing Indigenous Scholarship for this research work.

References

Citation: Sultana N, Saeed Arayne M, Ali SN (2013) Spectrophotometric Studies of Lamotrigine Charge Transfer Complexes: Synthesis and Characterization. Pharm Anal Acta 4:260.

Copyright: © 2013 Sultana N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.